Wall Street Splits Uber: Goldman Cuts Target, Piper Hikes
Uber’s first-quarter results sparked a rare split on Wall Street: Goldman Sachs trims the stock target, while Piper S...
When To Convert For Couples Roth Strategy
Explore conversion timing for a two-earner couple, including tax impact, income thresholds, and optimal years to convert for long-term growth.
18,272 articlesCrinetics (CRNX) 2026 Earnings Outlook and Analysis
Investors are watching Crinetics' Q1 2026 results for clues on milestones, cash runway, and partnerships. This guide ...
UK Moves Warship to Middle East as Hormuz Tensions Escalate
Britain pre-positions HMS Dragon in the Middle East as part of plans for a Europe-led mission to escort ships through...
AST SpaceMobile Earnings Miss Triggers Spacemobile Decline
AST SpaceMobile posted disappointing quarterly revenue in after-hours trading, triggering a drop in spacemobile’s sto...
Google at 52-Week High: Buy, Sell or Hold Right Now
Alphabet's Google rockets to a fresh 52-week high on AI and Cloud strength, yet investors juggle elevated capital exp...
Ford Today: Outperforming Other Car Stocks Amid Rally
Ford shares jumped roughly 7% as Q1 momentum and Ford Pro strength lifted the full-year EBIT outlook, putting Ford ah...
Reasons Into Hantavirus-Related Biotech: 3 Cautions
A hantavirus outbreak can spark biotech chatter, but three solid realities—limited demand, tough development paths, a...
Forget UnitedHealth: Two Stocks to Buy Now for 2026
Regulatory pressure around UnitedHealth shifts attention to two defensible, cash-generating stocks with strong divide...
Surgical Robotics Meets Intuitive: AI Boosts MedTech Stocks
AI-enabled surgical robotics are turning hospitals into data hubs. Intuitive Surgical, Medtronic, and Stryker sit at ...
Time Latin America's Fintech: Is It Worth Buying Now?
Latin America's fintech leaders have faced a choppy earnings season, but patient investors see potential. This guide ...
Billionaire Griffin Used Dismiss: AI Shift Reshapes Markets
Ken Griffin, the Citadel founder once openly skeptical of AI, has pivoted to embracing its potential, telling audienc...
UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status